Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs LII✓SelectedUSD · LIIGSK vs LII performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs LII

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+7.3%
LII return
-28.5%
Excess return
+35.8%
Maximum drawdown
-22.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 1y.

Portfolio and benchmark returns by period
PeriodPortfolioLIIExcessAlpha
1D-2.3%-0.9%-1.4%-2.2%
7D-3.0%-4.5%+1.5%-2.3%
30D+0.4%-7.1%+7.5%+1.6%
3M-1.2%-19.9%+18.7%+2.0%
6M+0.9%-33.2%+34.1%+5.5%
YTD+4.0%-31.0%+35.0%+5.7%
1Y+7.3%-26.9%+34.2%+6.4%
All+7.3%-28.5%+35.8%+6.4%

Cumulative growth

Daily Returns

Daily percentage return beside LII.

Daily Out/Under-Performance

Portfolio return minus LII return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × LII return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 1y: compounded portfolio wealth divided by compounded LII wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

1y analysis · Full analysis span regression · 6 months rolling